Syndax Pharmaceuticals Inc., a commercial-stage biopharmaceutical company focusing on innovative cancer therapies, is set to participate in Citi's 2025 BioPharma Back to School Conference. The event will feature a fireside chat with Chief Executive Officer Michael A. Metzger and the Syndax management team on Tuesday, September 2, 2025, at 4:45 p.m. ET.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.